Exane Derivatives’s Johnson & Johnson JNJ Stock Holding History

Exane Derivatives’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.88M	Buy	10,612 +4,965	+88%	+$885K	1.08%	18
2022 Q1	$1M	Sell	5,647 -3,810	-40%	-$648K	0.28%	92
2021 Q4	$1.62M	Sell	9,457 -2,386	-20%	-$391K	0.39%	51
2021 Q3	$1.91M	Buy	11,843 +2,450	+26%	+$418K	0.46%	40
2021 Q2	$1.59M	Sell	9,393 -4,517	-32%	-$748K	0.36%	58
2021 Q1	$2.29M	Buy	13,910 +7,765	+126%	+$1.26M	0.65%	36
2020 Q4	$967K	Buy	6,145 +4,105	+201%	+$606K	0.28%	92
2020 Q3	$304K	Buy	2,040 +216	+12%	+$32K	0.09%	177
2020 Q2	$256K	Buy	1,824 +755	+71%	+$110K	0.07%	203
2020 Q1	$140K	Sell	1,069 -419	-28%	-$59.4K	0.04%	239
2019 Q4	$219K	Buy	+1,488	New	+$202K	0.04%	241
2016 Q3	–	Sell	-2,027	Closed	-$246K	–	643
2016 Q2	$246K	Buy	+2,027	New	+$230K	0.04%	190
2016 Q1	–	Sell	-5,285	Closed	-$547K	–	605
2015 Q4	$543K	Sell	5,285 -7,106	-57%	-$715K	0.07%	112
2015 Q3	$1.16M	Buy	12,391 +1,973	+19%	+$191K	0.15%	82
2015 Q2	$1.02M	Buy	10,418 +5,249	+102%	+$526K	0.11%	90
2015 Q1	$520K	Buy	5,169 +75	+1%	+$7.63K	0.06%	139
2014 Q4	$533K	Buy	+5,094	New	+$537K	0.07%	136

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Exane Derivatives's JNJ Position: Q2 2022 in Review

Exane Derivatives increased its Johnson & Johnson (JNJ) stake by 88% in Q2 2022, buying an estimated $885K and bringing the position to 10,612 shares worth $1.88M. The position accounts for 1.08% of the portfolio, ranked #18.

Exane Derivatives first reported a position in JNJ in Q4 2014 and has held it in 17 quarters since. The position peaked at $2.29M in Q1 2021. 3,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

Exane Derivatives held 10,612 shares of Johnson & Johnson worth $1.88M as of Q2 2022.
Exane Derivatives bought 4,965 Johnson & Johnson shares in Q2 2022, an estimated $885K.
Johnson & Johnson made up 1.08% of Exane Derivatives's portfolio in Q2 2022, its #18 holding.
Exane Derivatives first reported a position in Johnson & Johnson in Q4 2014 and has held it in 17 quarters since.
Exane Derivatives's Johnson & Johnson position peaked at $2.29M in Q1 2021.
3,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.